Lung cancer is the most common cancer and the leading cause of cancer death in the world, accounting for approximately 1.8 million new cases (13% of all cancer cases) and 1.6 million deaths (20% of all cancer deaths) annually. 1 Most lung cancer patients are diagnosed at advanced stages when the possibility of cure is low, resulting in an overall 5-year survival rate of ~18% in the United States (US) and even lower in other countries. [2] [3] [4] While prognosis of lung cancer largely depends on clinical and pathological factors, such as stage, histologic type, treatment options, and patients' demographics and comorbidity status, 2, 5, 6 emerging evidence suggests that prediagnostic nutrition and lifestyle factors may also influence lung cancer survival.
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Both experimental and epidemiological studies have suggested potential roles of calcium in cancer development and progression. 10 Besides its well-known effects on bone health, calcium intake and calcium homeostasis can directly or indirectly affect cell proliferation, differentiation, and apoptosis, parathyroid hormone (PTH) and PTH-related peptide, vitamin D metabolism and signaling, angiogenesis, and immune response. 11, 12 Prospective cohort studies and meta-analyses of cohort studies have linked sufficient calcium intake with a decreased overall cancer risk and risks of specific cancers, including colorectal, breast, and prostate cancers. [13] [14] [15] [16] [17] [18] [19] Evidence, although limited, has also linked calcium intake with risk of lung cancer. 20, 21, 22 To our knowledge, only a very few cohort studies have examined the association of prediagnostic calcium intake with cancer survival, and none have examined the association with lung cancer survival. 23, 24 The aim of the present analyses is to investigate prediagnostic calcium intake from foods and supplements in relation to lung cancer survival. This is part of a large pooling project that collected individual-level data from nearly 1.9 million participants from 12 cohort studies in the US, Europe, and Asia (The Calcium and Lung Cancer Pooling Project). The present paper focuses on the association of prediagnostic calcium intake with lung cancer survival among 23 ,882 incident cases who were diagnosed with primary lung cancer during cohort follow-ups.
We examined the association among all cases combined and separately by major lung cancer prognostic factors, including age, stage, and histology.
Methods

Study Population
Twelve large, prospective cohort studies participated in The Calcium and Lung Cancer Pooling Project, including eight US cohorts: the National Institutes of Health-AARP study (NIH-AARP), 25 the Health Professionals' Follow-Up Study (HPFS), 26 the Nurses' Health Study I (NHS), 27 the Iowa Women's Health Study (IWHS), 28 
Assessment of Dietary and Supplemental Calcium Intake
Usual dietary intakes were assessed at baseline in each cohort using a self-or intervieweradministered food-frequency questionnaire (FFQ). The FFQs usually inquired about the average consumption of common food items over the past 12 months and were validated against 24-hour dietary recalls, 7-day food records, or dietary biomarkers. Daily food intakes were estimated based on the frequency and amount of consumption and were linked to country-specific food composition tables to calculate intakes of energy (kcal/d), calcium (mg/d), and other nutrients.
Details on the FFQs, calibration studies, and estimation of nutrient intake can be found in previous publications. [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] In the present study, dietary intakes were adjusted for total energy intake using the nutrient density method 49 and standardized to intakes per 2,000 kcal for women and per 2,500 kcal for men.
Intake of supplemental calcium was assessed in eight US cohorts. Participants were asked whether in the past year they generally took supplements (multivitamins and/or single calcium supplements); and if yes, how often (from less than once per week to every day) and how much they usually took (from less than 200 mg/d to more than 1000 mg/d for calcium). Most cohorts estimated supplemental calcium intakes from both calcium supplements and multivitamins, except that the SCCS asked only about the use of calcium supplements.
Assessment of Lung Cancer Incidence and Survival
Incident cancer cases and the vital status of cancer patients were identified in each cohort through linkages with regional or national cancer registries and death registries, follow-up interviews with cohort participants or their next of kin, review of medical records and/or death certificates, or these methods combined. Cancers of the bronchus and lung were ascertained by 
Assessment of Non-dietary Covariates
Each study collected baseline information on sociodemographics, lifestyles, medical history, and
anthropometrics. We harmonized these data and generated uniform variables to be used in the did not collect information on education level; we imputed these two variables using the above described method in JPHC Cohort I and II data combined.
Analytic population
Participants were excluded if they had 1) a history of any cancer except non-melanoma skin cancer prior to diagnosis of lung cancer, 2) missing diagnosis or survival time information, 3) missing calcium intakes or smoking status information, or 4) implausible total energy intake (beyond three standard deviations of the cohort-and sex-specific log-transformed mean energy intake or beyond the pre-determined range in six cohorts: HPFS, NHS, IWHS, SCCS, VITAL, and WHI). A total of 24,440 first, primary lung cancer cases diagnosed after the baseline survey among 1,679,842 eligible participants of the Calcium and Lung Cancer Pooling Project were considered eligible for the current study. We further excluded 11 cases with cancer in situ and 547 cases that had missing data on both stage and histology, leaving a total of 23,882 incident lung cancer cases in the present analyses.
Statistical Analysis
Usual dietary calcium intakes were calculated and compared among lung cancer patients with different baseline characteristics and tumor features using the general linear model (adjusted for age at baseline, sex, and total energy intake). Corresponding 5-year survival rates were estimated by the life- Stratified analyses were performed by potential effect modifiers, including age at diagnosis, sex, race/ethnicity, education, smoking, other lifestyle factors, stage, histologic type, grade, and time interval between dietary assessment and cancer diagnosis. P for interaction was evaluated via likelihood ratio test comparing models with and without the interaction term (calcium intake category × stratification variable). A series of sensitivity analyses were conducted by excluding those diagnosed with lung cancer within two years after the baseline, by excluding those who died or were lost to follow-up within three months after lung cancer diagnoses, or by examining lung cancer-specific mortality. Meta-analysis was applied as an alternative approach to pooled analysis. Cohort-specific HRs and 95% CI were calculated and then combined using a fixedeffect model because no significant between-study heterogeneity was detected. Finally, we explored the associations of lung cancer survival with three major calcium food sources: dairy products, green leafy vegetables, and soy foods. Two-sided P values of <0.05 were considered statistically significant. All analyses were conducted using SAS software, version 9.4 (SAS Institute, Inc.).
Results
Among ~1.7 million men and women from 12 cohort studies, 23,882 incident primary lung cancer cases were identified during a median follow-up of 7 years (interquartile range: 4-10 years (Table 2 ).
Stratified analysis showed that the association of a low prediagnostic calcium intake with poor lung cancer survival was more evident in men than in women (P for interaction = 0.01), and in early-stage cases than in distant-stage cases (P for interaction = 0.006) (Figure 1 ). In particular, a low calcium intake (<0.5 RDA) was associated with a 15% increased mortality in male patients (95% CI: 6-25%), and a 15% increase in localized or regional stage patients (95% CI: 4-27%) compared with the recommended level of calcium intake. The association appeared slightly stronger in White and Asian patients than in Black patients and in never smokers than in ever smokers; however, neither P for interaction was significant. We did not observe significant interactions by other potential effect modifiers ( Figure 1 ).
We thereafter focused our analyses among early-stage lung cancer cases (n=8,103). The risks of death by different levels of prediagnostic calcium intake are shown in Meanwhile, among patients who had no or little supplemental calcium intake, the HR (95% CI) for a low dietary calcium intake (<0.5 RDA vs. RDA) was 1.17 (1.02, 1.35).
In cubic spline modeling, the lowest mortality among early-stage lung cancer patients was observed for dietary calcium intakes of 800-1200 mg/d (Figure 2a , P = 0.03). Consistent with the above findings, low dietary calcium intake was associated with increased mortality, especially among early-stage male patients (Figure 2b ). Meanwhile, very high calcium intake might also be associated with increased mortality among early-stage female patients (Figure 2c ), although the confidence interval was very wide.
Results were robust in sensitivity analyses and in meta-analysis. The HRs (95% CI) in earlystage cases for low dietary calcium intake were 1.14 (1.02, 1.28) after excluding those diagnosed with lung cancer within two years after baseline (n=6,362), 1.17 (1.05, 1.30), after excluding those who died within three months after lung cancer diagnosis (n=7,246), 1.15 (1.02, 1.28) for lung cancer-specific deaths, and 1.14 (1.02, 1.28) in a fixed-effect meta-analysis (P for heterogeneity = 0.39) (Supplemental Figure 1) . Among major calcium-contributing foods, a higher intake of green leafy vegetables was associated with a better lung cancer survival; the were found for dairy products and soy foods.
Discussion
In this large pooled analysis of 12 cohort studies, we observed that a low prediagnostic dietary calcium intake (<500-600 mg/d) was associated with a slightly increased risk of death among lung cancer patients, after taking other prognostic factors into account. The lowest case mortality was observed for dietary calcium intakes of 800-1200 mg/d; any further increase in calcium intake did not offer additional benefit. The association between low prediagnostic calcium intake and lung cancer survival was primarily confined to patients diagnosed at early stages. No significant association was found for prediagnostic supplemental calcium intake with lung cancer survival.
For the first time, our study provides epidemiological evidence that a long-term insufficient calcium intake may influence lung cancer prognosis, especially for early-stage patients. Most of the patients in our study were diagnosed before 2010 when targeted treatments were less common and lung cancer treatments were largely dependent on stage, histologic type, and patient sociodemographics. We have adjusted for all these factors and stratified by cohort (region) and year of diagnosis in the analyses. We also conducted a number of subgroup analyses and did not find significant effect modifications by these factors except stage. Moreover, we found little evidence that patient tumor characteristics, including stage and histology, were associated with prediagnostic calcium intake, suggesting that these clinical factors were unlikely to substantially confound the association between usual calcium intake and lung cancer survival. Third, despite the large number of lung cancer patients followed, statistical power remained limited in certain analyses, such as the interaction analysis by race/ethnicity (due to a small number of black participants) and the analysis among never smokers. Finally, we could not separate the effects of calcium from related nutrients, including vitamin D, magnesium, phosphorus, and other nutrients in calcium-rich foods (dairy products, soy foods, and green leafy vegetables), that may contribute to the observed associations. Particularly, the association of prediagnostic green leafy vegetable intake with better lung cancer survival is worth further investigation. We also could not rule out the possibility of residual confounding from unknown confounders and imperfectly measured covariates, which may be particularly challenging in pooling projects that use harmonized data from multiple studies.
Strengths of our study include its prospective design, large sample size, and pooled data analysis. By including only prospective cohort studies and first primary lung cancer cases, we minimized the reverse causality and biases of recall and selection. By obtaining individual-level data from 12 cohort studies in three continents, we established one of the largest cohort consortia for investigation of nutrition on lung cancer risk and prognosis, with common variables on prediagnostic diet and lifestyle habits, cancer diagnosis, tumor characteristics, and survival status. This enabled us to evaluate the associations among populations with a broad range of exposures and clinical characteristics (such as extremely low and high calcium intake and early stage of lung cancer), which would be difficult for any single cohort study to investigate. Access to individual-level data also allowed us to examine calcium intake via multiple approaches, i.e.
using project-wide cut points as continuous variables and in a series of sensitivity analyses.
Results for low dietary calcium intake and poorer survival were largely consistent when different statistical approaches were used.
In summary, in this pooled analysis of 12 cohort studies, we found that low prediagnostic dietary calcium intake (<500-600 mg/d) was associated with a small but significantly increased risk of death among localized and regional stage lung cancer patients. Very high calcium intake (>1800 mg/d), a possible indication of previous history of calcium deficiency, was also associated with poorer survival for early-stage female patients. More studies are needed to explore biological mechanisms linking calcium nutrition, calcium homeostasis, bone remodeling, and bone metastasis with lung cancer progression, as well as to investigate modifiable nutrition and lifestyle factors to reduce risk and improve survival for lung cancer, the most deadly cancer of all. for men ≤70 y and women ≤50 y, or less than 600 mg/d for men >70 y and women >50 y.
Recommended intake was defined as calcium intake between the estimated average requirement (EAR) and RDA, which is 800-1000 mg/d for men ≤70 y and women ≤50 y, or 1000-1200 mg/d for men >70 y and women >50 y. The same stratified, multivariable-adjusted Cox model was used as shown in the footnote of Table 2 . 
